Related references
Note: Only part of the references are listed.β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway
Allisson Freire Bento et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Gastrointestinal and liver adverse effects of drugs used for treating IBD
Gerhard Rogler
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?
Gionata Fiorino et al.
CURRENT DRUG TARGETS (2010)
Endocannabinoid biosynthesis and inactivation, from simple to complex
Giulio G. Muccioli
DRUG DISCOVERY TODAY (2010)
Mechanisms and Efficacy of Immunobiologic Therapies for Inflammatory Bowel Diseases
Nilanjan Ghosh et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2010)
Inhibition of titanium particle-induced inflammatory osteolysis through inactivation of cannabinoid receptor 2 by AM630
D. C. Geng et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2010)
Effects of a Cannabinoid Receptor 2 Selective Antagonist on the Inflammatory Reaction to Titanium Particles In Vivo and In Vitro
F. Zhou et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
The endocannabinoid system links gut microbiota to adipogenesis
Giulio G. Muccioli et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
William R. Marrs et al.
NATURE NEUROSCIENCE (2010)
Future biologic targets for IBD: potentials and pitfalls
Gil Y. Melmed et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn's Disease
Martin Storr et al.
PLOS ONE (2010)
Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease
Miyuki Nishimura et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism
Jonathan Z. Long et al.
CHEMISTRY & BIOLOGY (2009)
Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages
Koichi Sugamura et al.
CIRCULATION (2009)
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
S. Brand
GUT (2009)
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
P. D. Cani et al.
GUT (2009)
Activation of the Cannabinoid 2 Receptor (CB2) Protects Against Experimental Colitis
Martin A. Storr et al.
INFLAMMATORY BOWEL DISEASES (2009)
Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-induced Colitis
Philip Alex et al.
INFLAMMATORY BOWEL DISEASES (2009)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Jonathan Z. Long et al.
NATURE CHEMICAL BIOLOGY (2009)
Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue
Lucia Marquez et al.
PLOS ONE (2009)
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
Jonathan Z. Long et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Distribution and function of monoacylglycerol lipase in the gastrointestinal tract
Marnie Duncan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain
Giulio G. Muccio et al.
ANALYTICAL BIOCHEMISTRY (2008)
The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats
A. Schaefer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Targeting endocannabinoid degradation protects against experimental colitis in mice:: involvement of CB1 and CB2 receptors
Martin A. Storr et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation
Kiarash Riazi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats
T. Croci et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
Jacqueline L. Blankman et al.
CHEMISTRY & BIOLOGY (2007)
Blockade of interferon-γ-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells
Kenji Suzuki et al.
PATHOLOGY INTERNATIONAL (2007)
Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells
Giulio G. Muccioli et al.
JOURNAL OF NEUROSCIENCE (2007)
The fundamental basis of inflammatory bowel disease
Warren Strober et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease
Oscar Pastor Rojo et al.
INFLAMMATORY BOWEL DISEASES (2007)
Evolving knowledge and therapy of inflammatory bowel disease
JR Korzenik et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation
G D'Argenio et al.
FASEB JOURNAL (2006)
Inflammatory bowel disease requires the interplay between innate and adaptive immune signals
DN Shi et al.
CELL RESEARCH (2006)
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597):: Effects on anandamide and oleoylethanolamide deactivation
D Fegley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The endogenous cannabinoid system protects against colonic inflammation
F Massa et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Functional disassociation of the central and peripheral fatty acid amide signaling systems
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol
N Ghafouri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease
C Banks et al.
JOURNAL OF PATHOLOGY (2003)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat
J Gálvez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
